Lonazolac

MUSCULO-SKELETAL SYSTEM

Key facts

Lonazolac is a drug catalogued in DrugCentral. DrugCentral lists 1 molecular target, including PTGES.

• Molecular targets: PTGES (1 listed in DrugCentral).
• ATC code: M01AB09 (Acetic acid derivatives and related substances).
• Molecular formula: C17H13ClN2O2; molecular weight 312.75 g/mol.

Mechanism & targets

Molecular targets (1)

Target	Gene	Action	Activity
Prostaglandin E synthase	PTGES	unknown	IC50 4.35

ATC classification

ATC code	Therapeutic hierarchy
M01AB09	MUSCULO-SKELETAL SYSTEM › ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS › ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS › Acetic acid derivatives and related substances

Chemical structure

• Molecular formula: C₁₇H₁₃ClN₂O₂
• Molecular weight: 312.75 g/mol
• CAS number: 53808-88-1
• InChIKey: XVUQHFRQHBLHQD-UHFFFAOYSA-N
• PubChem CID: 68706

OC(=O)CC1=CN(N=C1C1=CC=C(Cl)C=C1)C1=CC=CC=C1

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

How does Lonazolac work?

Its molecular targets in DrugCentral include PTGES.

What is the chemical formula of Lonazolac?

Lonazolac has the molecular formula C17H13ClN2O2 and a molecular weight of 312.75 g/mol.

Sources

• DrugCentral drug card 1597 — structure, indications, targets, approvals, pharmacologic classes (CC BY-SA 4.0)
• ChEMBL CHEMBL1334692 — compound record and bioactivity
• PubChem CID 68706 — chemical identifiers
• DrugBank DB13432 — drug record
• FDA UNII 13097143QI — substance identity
• UniProt O14684 (PTGES) — target protein

How this page is built: methodology · editorial policy & corrections.